US Stock MarketDetailed Quotes

NeuroOne Medical (NMTC)

Watchlist
  • 0.8990
  • +0.0291+3.35%
Close Jan 15 16:00 ET
  • 0.8990
  • 0.00000.00%
Pre 04:07 ET
45.32MMarket Cap-9.99P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

NeuroOne Medical (NMTC) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Sep 30, 2025
(Q4)Sep 30, 2025
(Q3)Jun 30, 2025
(Q2)Mar 31, 2025
(Q1)Dec 31, 2024
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
Total revenue
163.47%9.1M
906.64%2.74M
105.39%1.7M
0.67%1.39M
234.90%3.27M
76.86%3.45M
-63.29%272.28K
31.10%825.78K
195.45%1.38M
753.25%977.65K
Operating revenue
163.47%9.1M
906.64%2.74M
105.39%1.7M
0.67%1.39M
234.90%3.27M
76.86%3.45M
-63.29%272.28K
31.10%825.78K
195.45%1.38M
753.25%977.65K
Cost of revenue
66.70%3.96M
823.86%1.21M
43.63%781.22K
-37.63%615.49K
89.40%1.35M
58.65%2.37M
-76.06%131.22K
40.82%543.9K
127.04%986.88K
460.61%711.34K
Gross profit
376.20%5.14M
983.65%1.53M
224.56%914.84K
97.50%771.06K
623.54%1.93M
136.50%1.08M
-27.16%141.06K
15.68%281.87K
1,139.31%390.42K
2,263.92%266.31K
Operating expense
-27.76%9.37M
-1.96%2.9M
-8.92%2.8M
5.33%3.45M
-94.10%215.68K
4.47%12.97M
-11.93%2.96M
-18.06%3.08M
-7.11%3.28M
106.36%3.66M
Selling and administrative expenses
-6.55%7.38M
-3.39%1.78M
-13.94%1.62M
-3.12%1.94M
-5.98%2.04M
14.08%7.9M
16.79%1.84M
1.00%1.88M
9.99%2M
30.64%2.17M
Research and development costs
-1.62%4.98M
0.39%1.12M
-1.02%1.18M
18.62%1.51M
-20.97%1.17M
-27.02%5.07M
-37.41%1.11M
-36.84%1.19M
-25.36%1.27M
-5.13%1.48M
Other operating expenses
---3M
--0
----
----
---3M
----
----
----
----
----
Operating profit
64.45%-4.23M
51.32%-1.37M
32.47%-1.89M
7.14%-2.68M
150.47%1.71M
0.57%-11.89M
11.00%-2.82M
20.41%-2.79M
17.44%-2.89M
-90.01%-3.39M
Net non-operating interest income expense
-45.89%-334.06K
0
-9.33K
0
-324.74K
-228.99K
-228.99K
0
0
0
Non-operating interest expense
45.89%334.06K
--0
--9.33K
--0
--324.74K
--228.99K
--228.99K
--0
--0
--0
Other net income (expense)
573.06%955.16K
18.60%-248.16K
1,397.79%395.06K
1,220.33%409.41K
775.16%398.85K
-310.86%-201.91K
-1,129.17%-304.87K
-36.39%26.38K
215.23%31.01K
-11.65%45.58K
Gain on sale of security
339.89%784.67K
---314.75K
--319.63K
--390.35K
--389.45K
---327.09K
----
----
----
----
Other non- operating income (expenses)
36.20%170.49K
199.70%66.59K
185.99%75.43K
-38.54%19.06K
-79.36%9.41K
30.72%125.18K
-24.99%22.22K
-36.39%26.38K
215.23%31.01K
-11.65%45.58K
Income before tax
70.73%-3.61M
51.67%-1.62M
45.77%-1.5M
20.47%-2.27M
153.37%1.79M
-3.87%-12.32M
-6.87%-3.35M
20.22%-2.77M
18.95%-2.86M
-93.04%-3.34M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
70.73%-3.61M
51.67%-1.62M
45.77%-1.5M
20.47%-2.27M
153.37%1.79M
-3.87%-12.32M
-6.87%-3.35M
20.22%-2.77M
18.95%-2.86M
-93.04%-3.34M
Net income continuous Operations
70.73%-3.61M
51.67%-1.62M
45.77%-1.5M
20.47%-2.27M
153.37%1.79M
-3.87%-12.32M
-6.87%-3.35M
20.22%-2.77M
18.95%-2.86M
-93.04%-3.34M
Minority interest income
Net income attributable to the parent company
70.73%-3.61M
51.67%-1.62M
45.77%-1.5M
20.47%-2.27M
153.37%1.79M
-3.87%-12.32M
-6.87%-3.35M
20.22%-2.77M
18.95%-2.86M
-93.04%-3.34M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
70.73%-3.61M
51.67%-1.62M
45.77%-1.5M
20.47%-2.27M
153.37%1.79M
-3.87%-12.32M
-6.87%-3.35M
20.22%-2.77M
18.95%-2.86M
-93.04%-3.34M
Basic earnings per share
80.43%-0.09
63.64%-0.04
70.00%-0.03
36.36%-0.07
142.86%0.06
29.23%-0.46
15.38%-0.11
50.00%-0.1
47.62%-0.11
-27.27%-0.14
Diluted earnings per share
80.43%-0.09
63.64%-0.04
70.00%-0.03
36.36%-0.07
142.86%0.06
29.23%-0.46
15.38%-0.11
50.00%-0.1
47.62%-0.11
-27.27%-0.14
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Sep 30, 2025(Q4)Sep 30, 2025(Q3)Jun 30, 2025(Q2)Mar 31, 2025(Q1)Dec 31, 2024(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023
Total revenue 163.47%9.1M906.64%2.74M105.39%1.7M0.67%1.39M234.90%3.27M76.86%3.45M-63.29%272.28K31.10%825.78K195.45%1.38M753.25%977.65K
Operating revenue 163.47%9.1M906.64%2.74M105.39%1.7M0.67%1.39M234.90%3.27M76.86%3.45M-63.29%272.28K31.10%825.78K195.45%1.38M753.25%977.65K
Cost of revenue 66.70%3.96M823.86%1.21M43.63%781.22K-37.63%615.49K89.40%1.35M58.65%2.37M-76.06%131.22K40.82%543.9K127.04%986.88K460.61%711.34K
Gross profit 376.20%5.14M983.65%1.53M224.56%914.84K97.50%771.06K623.54%1.93M136.50%1.08M-27.16%141.06K15.68%281.87K1,139.31%390.42K2,263.92%266.31K
Operating expense -27.76%9.37M-1.96%2.9M-8.92%2.8M5.33%3.45M-94.10%215.68K4.47%12.97M-11.93%2.96M-18.06%3.08M-7.11%3.28M106.36%3.66M
Selling and administrative expenses -6.55%7.38M-3.39%1.78M-13.94%1.62M-3.12%1.94M-5.98%2.04M14.08%7.9M16.79%1.84M1.00%1.88M9.99%2M30.64%2.17M
Research and development costs -1.62%4.98M0.39%1.12M-1.02%1.18M18.62%1.51M-20.97%1.17M-27.02%5.07M-37.41%1.11M-36.84%1.19M-25.36%1.27M-5.13%1.48M
Other operating expenses ---3M--0-----------3M--------------------
Operating profit 64.45%-4.23M51.32%-1.37M32.47%-1.89M7.14%-2.68M150.47%1.71M0.57%-11.89M11.00%-2.82M20.41%-2.79M17.44%-2.89M-90.01%-3.39M
Net non-operating interest income expense -45.89%-334.06K0-9.33K0-324.74K-228.99K-228.99K000
Non-operating interest expense 45.89%334.06K--0--9.33K--0--324.74K--228.99K--228.99K--0--0--0
Other net income (expense) 573.06%955.16K18.60%-248.16K1,397.79%395.06K1,220.33%409.41K775.16%398.85K-310.86%-201.91K-1,129.17%-304.87K-36.39%26.38K215.23%31.01K-11.65%45.58K
Gain on sale of security 339.89%784.67K---314.75K--319.63K--390.35K--389.45K---327.09K----------------
Other non- operating income (expenses) 36.20%170.49K199.70%66.59K185.99%75.43K-38.54%19.06K-79.36%9.41K30.72%125.18K-24.99%22.22K-36.39%26.38K215.23%31.01K-11.65%45.58K
Income before tax 70.73%-3.61M51.67%-1.62M45.77%-1.5M20.47%-2.27M153.37%1.79M-3.87%-12.32M-6.87%-3.35M20.22%-2.77M18.95%-2.86M-93.04%-3.34M
Income tax 0000000000
Net income 70.73%-3.61M51.67%-1.62M45.77%-1.5M20.47%-2.27M153.37%1.79M-3.87%-12.32M-6.87%-3.35M20.22%-2.77M18.95%-2.86M-93.04%-3.34M
Net income continuous Operations 70.73%-3.61M51.67%-1.62M45.77%-1.5M20.47%-2.27M153.37%1.79M-3.87%-12.32M-6.87%-3.35M20.22%-2.77M18.95%-2.86M-93.04%-3.34M
Minority interest income
Net income attributable to the parent company 70.73%-3.61M51.67%-1.62M45.77%-1.5M20.47%-2.27M153.37%1.79M-3.87%-12.32M-6.87%-3.35M20.22%-2.77M18.95%-2.86M-93.04%-3.34M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 70.73%-3.61M51.67%-1.62M45.77%-1.5M20.47%-2.27M153.37%1.79M-3.87%-12.32M-6.87%-3.35M20.22%-2.77M18.95%-2.86M-93.04%-3.34M
Basic earnings per share 80.43%-0.0963.64%-0.0470.00%-0.0336.36%-0.07142.86%0.0629.23%-0.4615.38%-0.1150.00%-0.147.62%-0.11-27.27%-0.14
Diluted earnings per share 80.43%-0.0963.64%-0.0470.00%-0.0336.36%-0.07142.86%0.0629.23%-0.4615.38%-0.1150.00%-0.147.62%-0.11-27.27%-0.14
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -